Dr. Anthony Fauci knew all along COVID-19 was designed as a bioweapon. The FOIA released e-mails tells us so.

This was in 2005. Dr. Fauci knew then HydroxyChloroQuine was effective against Covid type viruses. “In the 1985-86 edition of Harrison’s Principles of Internal Medicine [a highly recommended book for students studying medicine in medical colleges], Dr. Fauci wrote that HCQ worked an anti-viral agent despite being an anti-malarial drug. There was no Covid-19 back then, but HCQ’s anti-viral properties were already well known.

In 2015 the only level-4 virus lab in the U.S. conducting defensive research against “Gain of function” viruses was closed because of the inherent danger to the population should the virus escape. Not to worry, President Obama, Melinda Gates and Dr Fauci started to look for a new place to conduct the research. They found it in Wuhan, China; the Chinese have no such scruples as danger to the people. This lab was taken over in 2017 by the Chinese army, conducting bio-weapon research (defensive only, of course), so the research continued, this time controlled by the Chinese.

In January 2017 Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said there is “no doubt” Donald J. Trump will be confronted with a surprise infectious disease outbreak during his presidency.

It is getting interesting. The virus escaped the lab, sometimes in the fall of 2019, and the Chinese knew it but kept silent. They closed off Wuhan to all other Chinese, rail, car and air. But they kept international travel open, as if they wanted the virus to spread all around the world. And Dr. Fauci knew it!

Thanks to a FOIA request from buzzfeed Dr. Faauci’s e-mails have been released. https://www.documentcloud.org/documents/20793561-leopold-nih-foia-anthony-fauci-emails

On page 2286 it clearly states that Covid-19 was designed in the lab as a bio-weapon!

There may be a cure for COVID-19 after all. Hydroxychloroquine (HCQ) works, both as a prophylactic and as cure if taken early.

In Indiatoday Prabhash K Dutta, New Delhi wrote in June 7, 2021:

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure.

Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in a prophylactic study published in the Journal of The Association of Physicians of India (JAPI) last week..

The study showed that hydroxychloroquine, popularly known as HCQ, could prevent SARS-CoV-2 infection in varying degrees depending on its dosing regimen. The highest prevention rate of 72 per cent was found among those given hydroxychloroquine over six weeks or a longer duration.

The study said, “[W]hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks reduced the probability of Covid positivity by 34 per cent, 48 per cent and 72 per cent.”

The study was conducted May-September last year when HCQ was still part of the Union health ministry’s recommendation in treatment protocol for Covid-19, and it began against the backdrop of contesting claims made by authorities and experts including Donald Trump and his advisor Dr Anthony Fauci, the US’s top infectious disease expert.

In March 2020, Donald Trump declared that hydroxichloroquine was a “game changer” drug in the fight against Covid-19. Dr Fauci dismissed the claim citing lack of study and evidence. Despite Fauci’s counter-positioning, Trump continued to be vocal about taking HCQ as prophylactic drug.

Incidentally, the Union health ministry on June 6 dropped hydroxychloroquine from Covid-19 treatment protocol. In its nine-page guidelines released on Sunday (June 6) by the directorate of health services, hydroxychloroquine, ivermectin and favipiravir find no mention.

The government’s decision came on the back of criticism by experts who pointed out a lack of study-based evidence to recommend hydroxychloroquine in Covid-19 cases. The government’s revised guidelines, however, contradicts the recommendations made by the Indian Council of Medical Research as released on May 17.

The ICMR guidelines prescribed the use of hydroxychloroquine in mild cases of Covid-19.

The authors of this prophylactic (relating to prevention of a disease) study said that this “is the largest multicenter study on HCQ prophylaxis on HCWs (healthcare workers), covering over 12,000 HCWs at the risk of Covid-19”.

The study was conducted in May-September last year across 44 hospitals in 17 states involving hundreds of doctors, who received doses of hydroxychloroquine.

One of the co-authors of the study, Dr Raj Kamal Choudhry said, “In the 1985-86 edition of Harrison’s Principles of Internal Medicine [a highly recommended book for students studying medicine in medical colleges], Dr. Fauci wrote that HCQ worked an anti-viral agent despite being an anti-malarial drug. There was no Covid-19 back then, but HCQ’s anti-viral properties were already well known.”

Dr Raj Kamal Choudhry, who was the nodal officer for the prophylaxis study of HCQ in Bihar’s Bhagalpur medical college, said, “We had given about 2,700 doctors and paramedical staff, laundry and kitchen people the prophylaxis of HCQs in the dose of HCQs 400 mg 1×2 for first day then 1 tab daily for 4 days.”

“We did not give to those who had palpitations and had QT prolongation [a measure of heart ailment]. Those who took this drug did not have Covid excepting 5 and 6. The effect was tremendous. Later, we gave this drug to all who had mild cases. Only those patients who were in ICU were not given.”

“Of 2,700 people who were given HCQs, 700 were doctors. Only five or six got infected with SARS-CoV-2 in Bhagalpur but none developed serious complications, and nobody died of Covid-19,” Dr Raj Kamal Choudhry told Indiatoday.in.

The evidence is piling up. There has been numerous, over 50 studies like this showing that HCQ is effective, both as prophylactic, and as an early cure. Yoo bad that the medical bureaucracy considered it more important to get rid of Donald Trump than to save over 100,000 lives in U.S. alone.

In addition HCQ is too cheap and generic to warrant a double blind study.

The other medication that may be as effective, and save lives is Ivermectin, an anti-parasite drug used to treat horses and other farm animals. You can buy it at Tractor Supply, so I have been told. I do not know proper dosages, but if done properly, it is safe for humans when treating parasitic infections. It also is too cheap for the medical community to take seriously.

One more thing, make sure you take supplemental Vitamin D3 (I take 5000 IU/day). An Indonesian study found that the death rate went from 95% if the values were less than 19 nanograms/milliliter to less than 5% if the D3 values were over 31 nanograms/milliliter. The study was made in Covid patients over 65 years old.

How many lives will be saved by wearing masks? Are there better alternatives?

I have counted the u.s covid-19 cases cases and deaths for the first week of April, and divided them by states requiring mask wearing and not requiring wearing masks. The mask wearing states had a death rate of 0.91% while the non mask wearing states had a death rate of 1.59%. The non mask wearing states had 244 deaths per day. This means we could have saved 244 (1.59-0,91)/1.59 = 103 lives per day as a nation if all were forced to wear a mask, everything else being equal (which of course it isn’t). (Look at Appendix 1 to see how your state is faring.)

Are there any better ways to save lives?

In March 2020 President Trump became a proponent of using HydroxyChloroQuine as a remedy for Covid-19. It was met with strong opposition from CDC and even scorn from his political opponents. CDC even published strong advice against using it to treat Covid-19, while still recommending its use to treat Lupus and rheumatoid patients with essentially no restrictions, including pregnant women and nursing mothers. After all, it had an over 50 year safety record as treatment for Malaria. Even Dr Fauci acknowledged its safety and efficacy as a cure for Coronaviruses as early as 2005, (see Appendix 2). Many countries are using HCQ as a first defense against COVID-19, and they experience on average less than half the death rate of nations that do not use HCQ as a first defense. To complicate matters, HCQ is prescribed to between 16 and 30% of all Covid cases in the U.S. As a guess with today’s 491 death’s per day, we could have saved more than 40%, about 200 lives a day, or twice as many lives as are saved by the mask mandate. The biggest problem for CDC is that HCQ is generic, cheap and easy to produce, so there is no profit in making a double blind study. For Trump opponents it was far more important to defeat Trump than to save a hunded thousand lives. ( see https://lenbilen.com/2020/09/06/u-s-a-corona-virus-death-rate-as-of-september-5-is-3-00-41-countries-have-higher-death-rates-15-countries-giving-hcqzincz-pac-to-covid-19-patients-as-soon-as-symptoms-occur-have-much-lower-death/ )

But there are other interesting cures for COVID-19, Ivermectin is fantastic. It has one problem, through.You can buy it at Tractor-supply, it is used as an antiparasitic agent for dogs and horses, and it is generic. However the worldwide interest is so big that at least 50 trials have been conducted and there is a 76% decrease in mortality. That means,using it properly would save nearly 400 lives per day.

see more at https://www.theblaze.com/op-ed/horowitz-who-data-ivermectin-reduces-covid-mortality-by-81-also-who-we-still-dont-recommend-it?utm_source=theblaze-breaking&utm_medium=email&utm_campaign=20210401Trending-IvemectinCovid&utm_term=ACTIVE%20LIST%20-%20TheBlaze%20Breaking%20News

Appendix 1

These are the U.S. states and territories with mask mandates:

State                          Cases Deaths Death rate   Cases    Deaths Death rate

                                      Last seven days         Total Since Pandemic started

Alabama                       305      18   5.90%        517,452    10,652   2.06%

Kansas                          183        8   4.37%        305,489     4,959   1.62%

California                  2688     109   4.06%      3,685,570   59,884  1.62%   

Kentucky                     538       18   3.35%         429,841     6,184  1.44%

Arkansas                      156         5   3.21%        331,505     5,660   1.71%  

Nevada                         309        8    2.59%        305,929    5,308   1.74%

New Mexico                200|        4   2.00%        192,989     3,963   2.05%

West Virginia              376         7   1.86%        144,820     2,735   1.89%

Guam                                                                     7,804        134   1.74%

Oregon                        468         8    1.71%      168,795      2,439   1,44%

Virginia                     1380       23   1.67%      631,083     10,436    1.65%

Louisiana                     363         6   1.65%        447,655   10,185   2.28%

District of Columbia    116     1.4   1.21%        45,498       1,077   2.37%

Massachusetts           2142       25   1.17%        650,573   17,358   2.67%

Maryland                   1311       15|   1.14%      421,823      8,410   1.99%

Puerto Rico                                                      210,181      2,139|   1.04% 

New York                  7552       76   1.01%     1,968,112   51,120   2.60%        

North Carolina          1526       15|   0.98%       924,810    12,212   1.32%

Indiana                         994        9    0.91%       693452     13,099   1.89%

Washington               1007         9    0.89%     375,725       5,368   1.43%

Ohio                           1900       17   0.89%     1,030,864   18,741   1.82%

U.S. Virgin Islands                                              2,945            26   0.88%

Wisconsin                    733         6   0.82%      582,643      6,667   1.14%

Pennsylvania             4162       27   0.75%   1,063,979    25,440    2.39%

Utah                             398        3    0.75%       388,426      2,139   0.55%

Illinois                        2982      20    0.67%   1.269,196    23,740   1.87%

New Jersey                4166       27   0.65%      942,311      24,783  2.63%

Hawaii                           97      0.6    0.62%       30,363          467   1.54%

Connecticut               1045         6    0.57%    319,779        7,940   2.48%

Michigan                    7226      40    0.55%     804,031     17,450   2.17%

New Hampshire          394         2    0.51%       86,035       1,250    1.45%

Colorado                    1481        7    0.47%     474,053       6,294    1.33%

Minnesota                  1931         9   0.47%     535,182       6,990    1.31%

Vermont                       164     0.7    0.43%       20,615          231    1.12%

Delaware                      320     1.1    0.34%       97,042       1,567   1.61%

Maine                           316     0.4    0.13%|      53,434          750   1.40%   

American Samoa                                                        0              0   0.00%

Total 48,929 447 0.91% 20,160,004 377,797 1,87%

These are the states and territories without mask mandates:

State                          Cases Deaths Death rate   Cases    Deaths Death rate

                                      Last seven days         Total Since Pandemic started

Montana                       144        6   4.17%        105,526      1,489  1.41%

Georgia                       1253     36   2.87%      1,068,199    19,305  1.81%

Mississippi                   209        6   2.87%       306,611      7,077  2.31%

Texas                          2,886    79    2.74%     2,817,742   49,124  1.74%

Iowa                             562      13   2.31%        384,173      5,843  1.52%

Nebraska                      274       6    2.19%        212,785     2,183  1.03%

Wyoming                        59    0.9  1.53%          56,802          701  1.23%

Missouri                       594        8   1.35%       581,164      9,196  1.58%

Arizona                        628        8   1.27%        846,230    17,023  2.01%

N.  Mariana Islands                                                 159|            2  1.26%      

South Carolina            1001    11   1.10%         559,597     9,237  1.65%

Idaho                             278       3   1.08%       182,841       1,989  1.09%

Florida                         5489    56   1.02%      2,096,747   33,844 1.61%

Tennessee                   1094     10   0.91%       820,965     11,997  1.46%

South Dakota                244    0.9   0.37%       119,197       1,939  1.63%  

North Dakota                154    0.3   0.19%       104,364       1,468  1.41%

Oklahoma                    275        0    0.00%       441,906      6,669  1.51%

Alaska                          172       0   0.00%          61,198          309  0.50%

Total 15,316 244 1.59% 10,766,206 179,393 1.67%

Appendix 2:

Dr Fauci also wrote about mask wearing during the Spanish Flu

With over 116 million COVID-19 cases in the world, how is USA doing compared to the rest of the world?

 

The table below shows that USA came in as number 28 of the 40 countries with the largest outbreak of the Wuhan virus. This table reflects the first 40 days of the new U.S. administration. Most countries have a declining death rate, with the notable exceptions of Mexico, South Africa, Germany, United Kingdom, Colombia, Poland, Romania, France, Spain, Pakistan, Russia, Portugal, Ukraine, Iraq, and the United States of America.

 

  Country                Cases             Deaths                Death Rate    

                               Mar 5             Mar 5             Mar 5           Jan 24    

World        ,116,779,394         2,593,566          2.22%           2.15%

  1. Mexico           2,119,305             189,578           8.95%           8.51%
  2. China                   89,962                 4,636           5.15%
  3. Iran                 1,681,682              60.594            3.60%           4.16%
  4. Peru                1,358,294              47,491            3.50%           3.62%                
  5. South Africa  1,518,979              50,566            3.33%           2.94%
  6. Italy                3,023,129              99,271            3.28%           3.48%
  7. Germany         2,493,887             72,297            2.90%           2,51%
  8. UK                    4.312,181            124,261            2.88%           2.71%
  9. Belgium             783,010              22,215            2,84%           3.00%
  10. Indonesia        1,373,836             37,154            2.70%           2.81%
  11. Colombia        2,269,582             60,300            2.66%           2.55%
  12. Poland            1,781,345               45,159           2.54%           2.41%
  13. Romania            824,995              20,854            2.53%          2.51%
  14. Canada               881,761             22,192            2.52%           2.56%
  15. Chile                   845,450             20,928            2.48%           2.55%
  16. Argentina       2,141,854             52,784            2.46%           2.51%
  17. Brazil            10,871,843            262,948           2.42%           2.45%
  18. France             3.859,102              88,274            2.29%          2.01%
  19. Spain               3,149,012              71,138           2.26%           2.08% 
  20. Pakistan            588,728               13,166            2.24%           2.12%
  21. Philippines        591,138               12,465           2.11%   
  22. Russia             4,312,181               88,726           2.06%          1.88%
  23. Portugal             808,405               16,486           2.04%           1.68%
  24. Ukraine           1,394,061              26,919            1.93%          1.84%
  25. Sweden              684,961               13,003           1.90%           2.02%
  26. Iraq                    723,189               13,548           1.87%           2.11%
  27. Japan                  436,728                8,119           1.86%
  28. USA               29,594,742             535,566          1.81%          1.67%
  29. Switzerland       562,290               10,041           1.79% 
  30. Morocco             485,567                  8,673          1.79%
  31. Austria               472,871                  8,694           1.78%
  32. Czechia            1,312,164               21,558          1.64%           1.65%
  33. Bangladesh        549,724                  8,451           1.54%         
  34. India              11,192,088              157,693          1.41%           1,44%
  35. Netherlands    1,110,213                15,762          1.42%           1.43%
  36. Jordan                417,934                  4,862           1.16%
  37. Turkey             2,757,460                28,901          1.05%          1.04%
  38. Serbia                 478,878                  4,525           0.94%
  39. Israel                  796,465                  5,834           0.73%           0.73%
  40. UAE                     408,236                  1,310           0.32%

Hydroxychloroquine + Zinc + Azithromycine + maybe vitamin D still the best treatment if administered early, not experimental vaccine still under medical trial (you will be tracked for 2 years).

This is getting interesting. I have been following the Hydroxychloroquine saga since President Trump started promoting it, and I heard from a medical receptionist how dangerous it was. Even Neil Cavuto of FOX news interviewed a doctor that stated it was very dangerous and Cavuto summarized ‘If you take this YOU WILL DIE”. Then on July 27 a group of medical personnel  gathered outside the Supreme Court for an impromptu press conference touting the benefits of Hydroxychloroquine. It was viewed 20 million times in a few hours and then promptly taken down by you-tube, Facebook, Instagram and twitter, among others.

There was a “Riot” on December 6 on the Capitol grounds, and a lot of people were basically invited to demonstrate in the Rotunda. One of the people that went in to the rotunda after being more or less ushered in was Dr. Simone Gold. (seen below). She used a bull horn for a short while , not to incite violence, but to try to inform people of the benefits of early treatments of the Wuhan virus and the unknowns consequences of the experimental vaccines available.

By being in the Rotunda on January 6 she is now a designated domestic terrorist according to most of the mainstream media.

Here is Dr. Simone Gould holding a seminar about the Wuhan virus and what we can do about it.

I ask you to see the whole video and draw your own conclusions. Does she seem to you to be a domestic terrorist as most of the media and prominent politicians assert, or is she trying to help bring forth the truth?

If you agree with her, you can sign this petition https://stopmedicaldiscrimination.org/

After 440,000 Americans are Dead — Facebook and American Journal of Medicine Admit Their Stand on HCQ was Wrong — These People Should be Prosecuted!

 

By Jim Hoft

Published January 28, 2021 at 11:49am

Back in August 2020 we wrote this on treating the coronavirus–

The liberal mainstream media can’t hide this truth from the American public forever.

The latest international testing of hydroxychloroquine treatment of coronavirus shows countries that had early use of the drug had a 79% lower mortality rate than countries that banned the use of the safe malaria drug.

This means that Dr. Fauci, Dr. Birx, the CDC, the liberal fake news media and the tech giants have been pushing a lie that has had deadly consequences!

America had lost (reportedly) over 150,000 lives at that time.

Today that number is at 440,000.

We now know that that number could have been lowered significantly if HCQ use would have been promoted in the US!

A new study posted in the American Journal of Medicine in January found that early treatment of coronavirus patients with hydroxychloroquine lowered the mortality rate for the disease.

The study found that immediate use of HCQ, while the patient was still at home, showed significant benefits.

This is just the latest study that shows the effectiveness of HCQ in treating the coronavirus.

For the past several months the website c19study.com has been tracking the HCQ-coronavirus studies.

Also today the Facebook Oversight Board announced it was overturning a previous case on the effectiveness of HCQ.

Facebook’s previously removed a post on the use of hydroxychloroquine in France which it claimed, “contributes to the risk of imminent… physical harm.”

According to c19study.com there have been 237 studies, 171 of which were peer reviewed that show 67% of patients improved in early treatment trials.

Also today the Facebook Oversight Board announced it was overturning a previous case on the effectiveness of HCQ.

Facebook’s previously removed a post on the use of hydroxychloroquine in France which it claimed, “contributes to the risk of imminent… physical harm.”

Today Facebook announced this was a mistake.

”’How many hundreds of thousands of victims were killed due to Dr. Fauci, the CDC and the tech giants’ false claims on hydroxychloroquine?

The jihad against HCQ was to get back at Trump. Hundreds of thousands of Americans are dead today!

When will these people face justice?”’

Vitamin D as COVID-19 fighter, a most important virus fighter!

The organization Grassroots health put out the results of 212 people that had the COVID-19 virus, roughly 50 each having a critical or severe or normal or mild outcome. The results were stunning. Nearly all with a high level of vitamin D level in the blood had a mild outcome, as opposed to those with a vitamin D deficiency.

Up to now vitamin D deficiency has mostly been a concern for the people with the following risk factors, but not as a virus fighter.

  • Osteoporosis or other bone disorder
  • Previous gastric bypass surgery
  • Age; vitamin D deficiency is more common in older adults.
  • Obesity
  • Lack of exposure to sunlight
  • Having a darker complexion
  • Difficulty absorbing fat in your diet

It should be fairly simple and fast to expand this analysis to a larger sample of people that also include people with antibodies to COVID-19 but never showed any symptoms.

If this holds true, we did the exact wrong thing by keeping people indoors in hope to slow the spread. Instead we should have encouraged people to be outdoors as much as possible, still practicing hygiene and social distance, give vitamin D to all over 65 (4000 IU), to all obese and people of dark complexion.

This is by no means the only suggestion, but it is one more weapon in the arsenal to combat this virus.

An Indonesian study indicates the link between Vitamin D Deficiency and death is even stronger:

 

It is correct special attention should be given African Americans and Native Americans, since they have a much higher rate of Vitamin D deficiency.

Conclusion: The AMA should start paying attention to food supplements and issue recommendations for Vitamin D that it is an  important therapeutic and prophylactic against COVID-19.

This also means that forbidding outdoor dining, forcing people to eat indoors in their own homes makes matters worse. This is also confirmed by the statistics of lockdown states, they do worse after lockdown than before. In contrast, states with less confinement are nearly all well past their peak.

 

 

American Medical Association Rescinds Previous Statement Against Prescription of Hydroxychloroquine to COVID-19 Patients. (Updated)

CHICAGO, IL – The American Medical Association (AMA), in a surprising move, has officially rescinded a previous statement against the use of Hydroxychloroquine (HCQ) in the treatment of COVID-19 patients, giving physicians the okay to return to utilizing the medication at their discretion.

Previously, the AMA had issued a statement in March that was highly critical of HCQ in regards to its use as a proposed treatment by some physicians in the early stages of COVID-19. In addition to discouraging doctors from ordering the medication in bulk for “off-label” use – HCQ is typically used to treat diseases such as malaria – they also claimed that there was no proof that it was effective in treating COVID, and that its use could be harmful in some instances.

However, on page 18 of a recent AMA memo, issued on October 30, (resolution 509, page 3) the organization officially reversed their stance on HCQ, stating that its potential for good currently may supersede the threat of any potential harmful side effects.

So, there we have it. HCQ could not be approved before the election, because President Trump had recommended it. Meanwhile, with an 8o +% reduced risk of having to be admitted to the hospital if administered with Azithromycin and Zinc as soon as testing positive or symptoms occurred, many (70000+) lives could have been saved.

It has come to my attention that the resolution, while adopted got stopped before a new and valid recommendation was issued. There are powerful interests in the AMA that want to keep things as they are rather than advance real medical science based on real results, and never admit a mistake. Meanwhile, people are dying because of lack of solid, but inexpensive medical solutions.

The recommendation is still up on their website, but should it disappear, here it is , the important part part.

AMERICAN MEDICAL ASSOCIATION HOUSE OF DELEGATES

Resolution: 509 (November 2020)

Introduced by: Georgia

Subject:Hydroxychloroquine and Combination Therapies – Off-Label Use

Referred to:Reference Committee E

Whereas, SARS-CoV-2 is the novel coronavirus that causes COVID-19; and

2 Whereas, Three distinct stages of COVID-19 infection have been observed in some people who test positive for the disease and have variable degrees of symptoms as noted (1); and

 

Whereas, During the early infection phase (Stage 1), the virus multiplies inside the body and is likely to cause mild symptoms that may be confused with a common cold or flu; and

Whereas, The second phase is the pulmonary phase (Stage 2), when the Immune System becomes strongly affected by infection and leads to primarily respiratory symptoms such as persistent cough, shortness of breath and low oxygen levels. Problems with blood clotting–especially with the formation of blood clots–may be predominant in Stage 2; and

Whereas, The third hyperinflammatory phase (Stage 3), occurs when a hyperactivated immune system may cause injury to the heart, kidneys, and other organs. A “cytokine storm”–where the body attacks its own tissues–may occur in this phase; and

Whereas, There is no current Federal Drug Administration (FDA) indication for the treatment of Early Coronavirus infection, but early emergency use authorization (EUA) originally approved the use of hydroxychloroquine and then rescinded it (2); and

Whereas, The FDA limited use of convalescence plasma but now has rescinded that limitation (3); and

Whereas, Hydroxychloroquine and Chloroquine are FDA approved medications for over 50 years, and these medications are safely prescribed long-term for other indications (2); and

Whereas, AMA President, Patrice A. Harris, MD, issued the following statement: “The AMA is calling for a stop to any inappropriate prescribing and ordering of medications, including chloroquine or hydroxychloroquine, and appealing to physicians and all health care professionals to follow the highest standards of professionalism and ethics” (4); and

Whereas, The AMA, American Pharmacists Association, and American Society of Health System Pharmacists issued a joint statement on March 25, 2020 on inappropriate ordering, prescribing, or dispensing of medications to treat COVID-19 (4); and

Whereas, Some states, pharmacy boards and institutions have forbidden the use of these medications for COVID-19 infection (4, 5); and

Whereas, A proposed regimen to treat COVID-19 for Stage 1, includes 10 days of hydroxychloroquine, Azithromycin, zinc, and on occasion Vitamin D (6); and

Whereas, This regimen is not being advocated for Stage 2 and Stage 3 COVID therapy; and

Whereas, The original studies published in The Lancet and The New England Journal of Medicine(NEJM) initially citing harm due to hydroxychloroquine and chloroquine use were retracted by said journals due to dubious research methodology and incorrect conclusions (7, 8, 9); and

Whereas, AMA policy H-120.988, “Patient Access to Treatments Prescribed by Their Physicians,” supports a physician’s autonomy to prescribe medications the physician believes to be in the patient’s best interest, where the benefits outweigh risk and the patient consents; and

Whereas, Physicians have used off label medications for years and this use is supported by existing policy; and

Whereas, Data regarding harm have been limited due to poorly designed studies or studies usually in Stage 2 or later, or stopped without harm but no effect in phase 2 and hypothesis (7, 8, 9, 10, 11, 12); and

Whereas, There are many studies that indicate that the use of Hydroxychloroquine, Azithromycin is effective and front-line physicians are using the therapy where permissible (13, 14, 15); and

Whereas, The COVID-19 pandemic is a serious medical issue, people are dying, and physicians must be able to perform as sagacious prescribers; therefore be it

RESOLVED, That our American Medical Association rescind its statement calling for physicians to stop prescribing hydroxychloroquine and chloroquine until sufficient evidence becomes available to conclusively illustrate that the harm associated with use outweighs benefit early in the disease course. Implying that such treatment is inappropriate contradicts AMA Policy H-120.988, “Patient Access to Treatments Prescribed by Their Physicians,” that addresses off label prescriptions as appropriate in the judgement of the prescribing physician (Directive to Take Action); and be it further

RESOLVED, That our AMA rescind its joint statement with the American Pharmacists Association and American Society of Health System Pharmacists, and update it with a joint statement notifying patients that further studies are ongoing to clarify any potential benefit of hydroxychloroquine and combination therapies for the treatment of COVID-19 (Directive to Take Action); and be it further

RESOLVED, That our AMA reassure the patients whose physicians are prescribing 18 hydroxychloroquine and combination therapies for their early-stage COVID-19 diagnosis by issuing an updated statement clarifying our support for a physician’s ability to prescribe an FDA-approved medication for off label use, if it is in her/his best clinical judgement, with specific reference to the use of hydroxychloroquine and combination therapies for the treatment of the earliest stage of COVID-19 (Directive to Take Action); and be it further

RESOLVED, That our AMA take the actions necessary to require local pharmacies to fill valid prescriptions that are issued by physicians and consistent with AMA principles articulated in AMA Policy H-120.988, “Patient Access to Treatments Prescribed by Their Physicians,” including working with the American Pharmacists Association and American Society of Health System Pharmacists.

(Directive to Take Action) Fiscal Note: Modest – between $1,000 – $5,000

Received: 10/23/20

References:

1. Stages of COVID-19. https://emergencymedicinecases.com/covid-19-screening-diagnosis-management/

2. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and

3. Recommendations for Investigational COVID-19 Convalescent Plasma. https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma

4. “The A.M.A. is calling for a stop to any inappropriate prescribing and ordering of medications, including chloroquine or hydroxychloroquine, and appealing to physicians and all health care professionals to follow the highest standards of professionalism and ethics,” said AMA President Patrice A. Harris, MD. The American Medical Association, American Pharmacists Association, and American Society of Health System Pharmacists issued a joint statement on March 25, 2020 on inappropriate ordering, prescribing or dispensing of medications to treat COVID-19. https://www.ama-assn.org/system/files/2020-04/board-of-pharmacy-covid-19-prescribing.pdf

5. Pharmacy Practice New. Rosenthal M. Hydroxychloroquine: Where Pharmacy, Medicine and Politics Intersect, Pharmacy Practice News August 8, 2020

6. Risch H. Opinion: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis Am J Epidemiol. 2020 May 27;kwaa093. doi: 10.1093/aje/kwaa093. Online ahead of print.

7. Piller C, Servick k. Two elite medical journals retract coronavirus papers over data integrity questions. https://www.sciencemag.org/news/2020/06/two-elite-medical-journals-retract-coronavirus-papers-over-data-integrity-questions#June 4, 2020

8. Lancet retraction website https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931180-6

9. NEJM Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI:

10.1056/NEJMoa2007621.

11. NIH halts clinical trial of hydroxychloroquine https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquineResolution: 509 (November 2020) Page 4 of 6

12. Filippo Albani F, Fusina F , Giovannini A et al. Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19. J. Clin. Med. 2020, 9, 2800; doi:10.3390/jcm9092800

13. Schwartz RA, Suskind RH DTH-9999-e13785 Azithromycin and COVID‐19Prompt Early Use at First Signs of this Infection in Adults and Children an Approach Worthy of Consideration. DTH-999-e13785 doi 10.1111/dth.13785

14. Meo SA, Klonoff DC, Akram J. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19 European Review for Medical and Pharmacological Sciences 2020; 24: 4539-4547

15. US ‘frontline’ doctors’ website exposes ‘criminal’ campaign by tech giants, govt agencies to block COVID med file:///C:/Users/JGoldman/Documents/Corona%20Virus/critique%20of%20HCQ/US%20%E2%80%98frontline%E2%80%99%20doctors%E2%80%99%20website%20exposes%20%E2%80%98criminal%E2%80%99%20campaign%20by%20tech%20giants,%20govt%20agencies%20to%20block%20COVID%20med%20_%20Blogs%20_%20Lifesitenews.html

Monulparivir: New Antiviral Drug That Completely Suppresses the Transmission of the COVID-19 in 24 Hours.

Dec 07, 2020 12:54 PM EST Madz D.(staff@moneytimes.com)

The COVID-19 vaccine would be the answer to end the pandemic. But even if the vaccine distribution starts today, it won’t be enough for all people who need it worldwide. 

A new antiviral drug, Molnupiravir or MK-4482 / EIDD-2801, can manage to “completely” stop the transmission of the virus within 24 hours, as per the Institute of Biomedical Sciences of Georgia State University studies.

Researchers explained in the published work in the journal Nature Microbiology that it is the first demonstration of an oral drug available to quickly block the transmission of SARS-CoV-2 that would be a game-changer.

According to Entrepreneur, Emory University in Atlanta developed Molnupiravir through an innovation company Drug Innovation Ventures at Emory (DRIVE), licensed by Ridgeback Biotherapeutics, and partnered with Merck & Co. The antiviral drug was initially being made to treat the flu and prevent the coronavirus from duplicating itself and creating errors amid viral RNA replication.

Tests were carried out on ferrets and observed that they reduced the number of viral particles and the experts’ details. Then, ferrets were put to others, which had not been treated. In the second group, none of the ferrets became infected with COVID-19.

Dr. Robert Cox, the co-lead author of the studyand a postdoctoral fellow in the Plumper group, said, “We believe that ferrets are a relevant transmission model. Because they easily spread SARS-CoV-2, but for the most part they do not develop a serious disease, which is very similar to the spread of SARS-CoV-2 in young adults.”

Cox added that they observed early that the antiviral drug has a broad-spectrum activity to fight respiratory RNA viruses. Besides, the oral treatment of infected animals with the Mogul Parivar reduced the number of viral particles spread by different magnitude orders, which reduced the transmission. Monulparivir’s properties are a powerful candidate for the pharmacological suppression of COVID-19, the report adds.

COVID-19 patients treated with the antiviral drug could be non-infectious within 24 hours of the initial treatment if the ferret-based data will be translated to humans. Monulparivir can be taken orally, and treatment can start early for a triple potential benefit: shortening the infectious phase to alleviate the emotional, shortening the infectious phase to lessen the emotional and socioeconomic cost of prolonged patient isolation immediately contain local outbreaks.

The antiviral drug is now on an advanced phase II/ III clinical trial and is being tested in three various doses every 12 hours within five days in patients with COVID-19. 

Americans are skeptical about the COVID-19 vaccines, with a “warp speed” timeline that blunts confidence and fears political interference in the shots. According to NBC News, two promising vaccines lead the release within weeks; experts in immunization behavior and ethics say they assume attitudes to shift from widespread hesitancy to urgent and heated demand.

 Dr. Paul Offit, a vaccinologist with Children’s Hospital of Philadelphia, said in a recent JAMA Network webinar, “People talk about the anti-vaccine people being able to kind of squelch uptake. I don’t see that happening.”

These are exciting days!

Have we found the cure to the flu?

In the days before antibiotics there was a cure for Syphilis: Give the patients malaria.The fever from malaria was so high that it killed the Syphilis bacteria. This was a drastic method but it worked.

Now CDC HAS FOUND THE CURE FOR FLU: CORONAVIRUS

This is a capture of the entirety of flu cases recorded by the CDC for the last 8 weeks.

https://www.cdc.gov/flu/weekly/weeklyarchives2020-2021/data/whoAllregt_phl48.html

Influenza Positive Tests Reported to CDC by U.S. Public Health Laboratories

2020-2021 A(H3N2v) A           A(H3) A(unable A(Subtyping  B BVIC BYAM Total

Season                         (H1N1)             to sub-           not                                       # Tested

Week                            pdm09                  type)     performed)

202040        0              0            0          0                2                  0    0       0          11433

202041        0              1            0          0                3                  2    1       0           11914

202042        0              0           1           0                4                  3    0       0          10960

202043        0             1            2           0                8                  1    0       2          15307

202044        0             0            2           0                4                11    1       2          19916

202045        0             1            1           0                5                 2    1       1           21439

202046        0             0            1           0                5                 2    0       0          20001

202047        0             2            2           0               0                  2    1       2          19418

202048        0             0            0          0                3                  1    1       0          10175

Week 48 ended November 29, 2000

We are now in the tenth week of the flu season and still no sign of the flu.

Have nearly all the flu cases been misdiagnosed as coronavirus, since coronavirus is the primary cause of everything found if the patient tests positive, or has all this social distancing and clean your hands prevented the seasonal flu outbreak?

We should all know from history that the major cause of the high death toll in the Spanish flu was not the flu itself but the ensuing pneumonia caused by the mask wearing mandate, masks that were seldom properly sterilized.

Seattle policemen wearing protective gauze face masks during influenza epidemic of 1918 which claimed millions of lives worldwide (Photo by Time Life Pictures/National Archives/The LIFE Picture Collection via Getty Images)